Company news
Quidelortho Corporation (NASDAQ:QDEL) news
Every Quidelortho Corporation press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Faster Answers, Better Decisions: ADLM 2026 Highlights
August 27, 2026
QuidelOrtho Reports Second Quarter 2026 Financial Results
August 6, 2026
QuidelOrtho to Report Second Quarter 2026 Financial Results
July 24, 2026
QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 15, 2026
QuidelOrtho Appoints Micah Young as Chief Financial Officer
June 23, 2026
QuidelOrtho and Allo Hope Foundation Join Forces to Advance Education, Connection and Early Testing for Alloimmunized Pregnancies
June 2, 2026
When Blood Compatibility Becomes a Pregnancy Risk
May 21, 2026
QuidelOrtho to Participate in Upcoming June 2026 Investor Conferences
May 20, 2026
QuidelOrtho : Quarterly Report for Quarter Ending March 29, 2026 (Form 10-Q)
May 6, 2026
QuidelOrtho Reports First Quarter 2026 Financial Results
May 5, 2026
Understanding and Addressing Syphilis Trends - and What's Being Missed
April 23, 2026
TTP Group Announces the Sale of LEX Diagnostics
April 20, 2026
QuidelOrtho Corporation Completes Acquisition of LEX Diagnostics
April 20, 2026
QuidelOrtho Announces Preliminary Revenue for the First Quarter 2026 and Provides Update on Full-Year 2026 Guidance
April 15, 2026
Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer
March 24, 2026
Faster Cardiac Answers with High‑Sensitivity Troponin
February 19, 2026
QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference
February 18, 2026
QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio
February 16, 2026
QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results
February 11, 2026
QuidelOrtho Receives Excellence Services Label in EMEA and Two Stevie® Awards
February 3, 2026
Strengthening the blood supply: Awareness, challenges and donor impact
January 22, 2026
QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results
January 21, 2026
Neogen® Announces Two Senior Leadership Appointments
January 5, 2026
Innovating Diagnostics and What's Next
December 18, 2025
QuidelOrtho To Participate In Upcoming Investor Conferences
November 24, 2025
The Power of Prevention: Detecting Diabetes Before It Strikes
November 20, 2025
QuidelOrtho Reports Third Quarter 2025 Financial Results
November 5, 2025
QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay
November 3, 2025
Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics
October 23, 2025
QuidelOrtho to Report Third Quarter 2025 Financial Results
October 22, 2025
QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025
October 16, 2025
Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters
September 25, 2025
QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use
September 22, 2025
QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference
August 28, 2025
Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities
August 21, 2025
QuidelOrtho Completes Debt Refinancing
August 21, 2025
QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development
August 19, 2025
QuidelOrtho Launches Certified Analyzer Program
August 13, 2025
QuidelOrtho Reports Second Quarter 2025 Financial Results
August 5, 2025
QuidelOrtho Recognized with Three Awards in 2025 IMV ServiceTrak™
July 29, 2025
Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast
July 24, 2025
QuidelOrtho to Report Second Quarter 2025 Financial Results
July 22, 2025
Real Labs, Actual Decisions With Actionable Six Sigma Metrics
July 17, 2025
QUIDELORTHO AND BÜHLMANN LABORATORIES AG ANNOUNCE AVAILABILITY OF FECAL CALPROTECTIN (FCAL®) TURBO AND FECAL PANCREATIC ELASTASE (FPELA®)...
July 14, 2025
QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs
July 7, 2025
QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics
June 3, 2025
QuidelOrtho to Participate in Upcoming Investor Conferences
May 22, 2025
QuidelOrtho Reports First Quarter 2025 Financial Results
May 7, 2025
QuidelOrtho to Report First Quarter 2025 Financial Results
April 23, 2025
QuidelOrtho® Introduces Results Manager™ System
March 10, 2025